Genetically modified mouse models for the study of nonalcoholic fatty liver disease
about
Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceHerbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospectsEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesHow Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?Ethnic differences in the link between insulin resistance and elevated ALT.Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis.Experimental models of non-alcoholic fatty liver disease in rats.Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse.Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceAdipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsGlobal publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic reviewWhat is the role of adiponectin in obesity related non-alcoholic fatty liver disease?The expanding role of fish models in understanding non-alcoholic fatty liver disease.Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.The liver diseases of lipodystrophy: the long-term effect of leptin treatment.Curcumin and liver disease.The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease.Update on pparγ and nonalcoholic Fatty liver disease.High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAsMurine models provide insight to the development of non-alcoholic fatty liver disease.Alcohol consumption and fatty liver disease.Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice.Metabolic profiling of ob/ob mouse fatty liver using HR-MAS 1H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway.Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
P2860
Q26769609-791BC7E5-216C-49E9-BA73-C44D2F7414B3Q26828615-FA03A895-5B6D-4F82-A4C0-3AA0BC984B9CQ27027733-E5B149A0-2B27-4FF9-8FD1-1C05708EB754Q28074455-868A37E3-2FE8-42EB-8D65-644D791217DDQ30411106-03AB2D4A-D36D-4BAB-BF71-34A29BB0C213Q33676162-92BB67AA-5B13-4293-9459-6B1BD8D84D44Q33886936-23A3055A-493B-400D-B3B6-C0695CE394ABQ34185231-839AFE1B-3DF6-4CD5-BBD4-4AB97B8277F3Q34397051-20EB205A-716E-4798-8EAE-B68082FF9DC9Q34779049-0D1D98B4-0038-4FE0-820A-5C9D92B0CA7EQ34800989-95F0A4BD-909B-41EB-8D9C-A4EE35DB826EQ36369189-57A2C474-8D94-4C32-8533-3650B341F6C8Q36616784-4E1DD14F-DD06-4B9A-AE80-4AAA12674F1CQ36981804-5A255A2A-705D-4FF7-8349-75F22C797225Q37266370-D4B8CAD3-5B30-48AE-92E3-8DA65E72167CQ37585164-1E140218-387E-47CD-8E57-33E9953132C2Q38072883-0D8E8ED5-8001-4916-B0F1-E34FC848536FQ38432731-9C9E0428-302C-48FF-940B-FDA091BD0D39Q38572366-4846002E-AB94-4E7C-AFE2-259D02E89EDCQ38790566-83F2F88E-4580-4B36-B6D0-F4C9F1CE56DCQ41903480-CCEB4644-E641-4599-B030-16A776455ECAQ41940630-64C91196-2BD8-4316-BAA7-52C7FAC8A216Q42134707-5B643F57-D5A4-472C-88B9-B4177EF495C8Q43198188-ED423247-EAEC-49A2-B5C7-10DE3BEAE1A4Q44665378-4C76C324-A4E5-40AB-BA83-032997017449Q50115683-5472657C-7B21-40C9-B98B-258853CAF727Q54753378-3FE09321-6EC1-443A-9FD4-40CBF937DE4E
P2860
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@ast
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@en
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@nl
type
label
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@ast
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@en
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@nl
prefLabel
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@ast
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@en
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@nl
P2860
P3181
P356
P1476
Genetically modified mouse models for the study of nonalcoholic fatty liver disease
@en
P2093
Perumal Nagarajan
P2860
P304
P3181
P356
10.3748/WJG.V18.I11.1141
P407
P577
2012-03-21T00:00:00Z